| Cat. No. |
Product Name |
Information |
| PC-72801 |
HB007
SUMO1 degrader
|
HB007 (HB-007) is a small-molecule degrader of the small ubiquitin-related modifier 1 (SUMO1) with anticancer potency in vitro and in vivo. |
| PC-72788 |
S62798
TAFIa inhibitor
|
S62798 (S 62798) is a highly selective human, mouse and rat TAFIa (Thrombin Activatable Fibrinolysis Inhibitor) inhibitor with IC50 of 11, 270, 178 nM respectively. |
| PC-72775 |
MTDH-SND1 inhibitor C26-A6
MTDH-SND1 inhibitor
|
MTDH-SND1 inhibitor C26-A6 is a specific inhibitor that disrupts the protein-protein interaction (PPI) between MTDH and SND1. |
| PC-72765 |
DC-SX029
SNX10 inhibitor
|
DC-SX029 is a new small-molecule sorting nexin 10 (SNX10) inhibitor (KD=0.935 uM), blocks the SNX10-PIKfyve interaction, decreases TBK1/c-Rel signaling activation. |
| PC-72762 |
CVN424
GPR6 inverse agonist
|
CVN424 (CVN 424) is a highly potent, selective, brain-penetrant, orally active GPR6 inverse agonist with EC50 of 38 nM. |
| PC-72748 |
PDDC
nSMase2 inhibitor
|
PDDC is the first potent, selective, orally-available, and brain-penetrable nSMase2 (neutral sphingomyelinase 2) inhibitor with pIC50 of 6.57. |
| PC-72746 |
Sari 59-801
|
SaRI 59-801 is an orally effective hypoglycemic compound, decreases blood glucose in several species and to elevate plasma insulin in rats and mice. |
| PC-72745 |
CHD1Li 6.11
CHD1L inhibitor
|
CHD1Li 6.11 (OTI-611) is a first in class, orally bioavailable oncogenic CHD1L inhibitor with 3.3 uM (CHD1L-cat enzyme activity). |
| PC-72727 |
T417
PBX1 inhibitor
|
T417 (PBX1 inhibitor T417, TCRS-417) is a novel small molecule compound capable of docking to the interface between PBX1 and its cognate DNA target sequence, potently interferes with the PBX1-DNA interaction with IC50 of 6.58 uM. |
| PC-72720 |
FGF23 inhibitor 13a
FGF23 inhibitor
|
FGF23 inhibitor 13a (FGF23-IN-13a) is a ZINC13407541 analogue with enhanced drug-like properties, inhibits FGF23 with IC50 of 0.14 uM. |
| PC-72719 |
ZINC13407541
FGF23 inhibitor
|
ZINC13407541 is a small molecule antagonist for FGF23, inhibits FGF-23 signaling with IC50 of 0.45 uM. |
| PC-72714 |
AAA-10
BSH inhibitor
|
AAA-10 (AAA10) is a second-generation gut-restricted pan-bile salt hydrolase (BSH) enzyme inhibitor. |
